Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02783300 |
| Title | Dose Escalation Study of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma (NHL) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications |
triple-receptor negative breast cancer ureter transitional cell carcinoma renal pelvis transitional cell carcinoma |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | FRA | CAN |